CAMPBELL, CA / ACCESSWIRE / March 14, 2019 / VIVUS, Inc. (NASDAQ: VVUS; the "Company"), a biopharmaceutical company, today announced that the Ministry of Health of the Russian Federation has approved ...
June 1, 2012 (Atlanta) — Avanafil (Stendra, Vivus) is well tolerated and effective in the treatment of erectile dysfunction (ED) in postprostatectomy patients who are diabetic, 65 years and older, and ...
VIVUS Announces Study Results Showing STENDRA (Avanafil) is Effective for Sexual Activity Within 15 Minutes in Men With Erectile Dysfunction (ED) Data From Successful Placebo-Controlled Study to be ...
Avanafil (Stendra, Vivus and Auxilium Pharmaceuticals) has been approved by the US Food and Drug Administration (FDA) to be taken by patients with erectile dysfunction (ED) as early as about 15 ...
An experimental erectile dysfunction drug - avanafil - promises erections in just 30 minutes or less, according to a study by the drug's manufacturer. The phase 3 study, not yet published in a ...
announced by the drug's manufacturer. welcome option for ED treatment ," Jones said in a news release from Vivus Inc., which has licensed the drug from Mitsubishi Tanabe Pharma Corp. receiving the ...
An experimental erectile dysfunction drug has shown promise in prompting erections in just 30 minutes or less, say researchers. The manufacturers claim that avanafil works faster than drugs like ...
The European Association of Urology 2014 guidelines on male sexual dysfunction define erectile dysfunction as the persistent inability to attain and maintain an erection sufficient to permit ...
Avanafil is prescribed to treat erectile dysfunction (ED). Do not take avanafil if you take nitrates, often prescribed for chest pain, as this may cause a sudden, unsafe drop in blood pressure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results